Silence Therapeutics plc
SLN· Nasdaq
Released Aug 10, 2026, before the open
10-Q filed Aug 10, 2026, 41 days after period end · 0001193125-26-341248
| Metric | Q2 2026 | Q2 2025 | Q2 2024 |
|---|---|---|---|
| Revenue | $0.00 | $224.00K | $756.00K |
| Net Income | -$12.27M | -$27.35M | -$19.76M |
| EPS Diluted | -$0.09 | -$0.19 | -$0.14 |
Silence Therapeutics plc · CIK 1479615 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.